Quince Therapeutics, Inc. (QNCX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $5.81M | -6.5% |
| 2024 | $6.21M | — |
| 2019 | $51.21M | +105.9% |
| 2018 | $24.87M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $5.81M | -6.5% |
| 2024 | $6.21M | — |
| 2019 | $51.21M | +105.9% |
| 2018 | $24.87M | — |